RU2009146829A - METHOD OF OBTAINING A2A-ADENOSINE RECEPTOR AGONIST AND ITS POLYMORPHIC MODIFICATIONS - Google Patents
METHOD OF OBTAINING A2A-ADENOSINE RECEPTOR AGONIST AND ITS POLYMORPHIC MODIFICATIONS Download PDFInfo
- Publication number
- RU2009146829A RU2009146829A RU2009146829/04A RU2009146829A RU2009146829A RU 2009146829 A RU2009146829 A RU 2009146829A RU 2009146829/04 A RU2009146829/04 A RU 2009146829/04A RU 2009146829 A RU2009146829 A RU 2009146829A RU 2009146829 A RU2009146829 A RU 2009146829A
- Authority
- RU
- Russia
- Prior art keywords
- temperature
- approximately
- ethanol
- filtering
- suspension
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract 23
- 229940122614 Adenosine receptor agonist Drugs 0.000 title 1
- 101150051188 Adora2a gene Proteins 0.000 title 1
- 238000012986 modification Methods 0.000 title 1
- 239000003379 purinergic P1 receptor agonist Substances 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract 16
- 239000007787 solid Substances 0.000 claims abstract 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract 9
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 claims abstract 8
- 150000001875 compounds Chemical class 0.000 claims abstract 8
- 238000001914 filtration Methods 0.000 claims abstract 8
- 239000000725 suspension Substances 0.000 claims abstract 8
- 238000001816 cooling Methods 0.000 claims abstract 7
- 238000001035 drying Methods 0.000 claims abstract 6
- 239000002904 solvent Substances 0.000 claims abstract 6
- 238000005406 washing Methods 0.000 claims abstract 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims abstract 4
- LZPZPHGJDAGEJZ-AKAIJSEGSA-N regadenoson Chemical compound C1=C(C(=O)NC)C=NN1C1=NC(N)=C(N=CN2[C@H]3[C@@H]([C@H](O)[C@@H](CO)O3)O)C2=N1 LZPZPHGJDAGEJZ-AKAIJSEGSA-N 0.000 claims abstract 4
- 239000012467 final product Substances 0.000 claims abstract 3
- 239000000047 product Substances 0.000 claims abstract 3
- 238000007872 degassing Methods 0.000 claims abstract 2
- 239000012535 impurity Substances 0.000 claims abstract 2
- 239000008213 purified water Substances 0.000 claims abstract 2
- 238000013022 venting Methods 0.000 claims abstract 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims 4
- HMFLBGNCDZYITR-UHFFFAOYSA-N ethyl 2-formyl-3-oxopropanoate Chemical compound CCOC(=O)C(C=O)C=O HMFLBGNCDZYITR-UHFFFAOYSA-N 0.000 claims 3
- 239000002253 acid Substances 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 230000003993 interaction Effects 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 239000011541 reaction mixture Substances 0.000 claims 1
- 238000010992 reflux Methods 0.000 claims 1
- 238000003756 stirring Methods 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
1. Способ получения (1-{9-[(4S,2R,3R,5R)-3,4-дигидрокси-5-(гидроксиметил)оксолан-2-ил]-6-аминопурин-2-ил}пиразол-4-ил)-N-метилкарбоксамида ! ! путем контактирования соединения формулы (4): ! ! с водным метиламином при температуре, равной приблизительно 2,5-7,5°С. ! 2. Способ по п.1, где реакцию проводят в герметичном реакторе под давлением. ! 3. Способ по п.2, где продукт выделяют посредством ! (а) дегазирования под вакуумом при температуре не более 35°С для удаления избыточного метиламина, ! (b) сбрасывания вакуума и охлаждения до 0-5°С в течение приблизительно от 15 мин до часа, ! (с) фильтрования образованной таким образом суспензии, ! (d) промывки содержимого фильтра водой и далее этанолом и ! (e) сушки оставшегося твердого вещества под вакуумом при температуре, которая не превышает 40°С. ! 4. Способ по п.3, где конечный продукт (1-{9-[(4S,2R,3R,5R)-3,4-дигидрокси-5-(гидроксиметил)оксолан-2-ил]-6-аминопурин-2-ил}пиразол-4-ил)-N-метилкарбоксамид дополнительно очищают посредством ! (i) растворения высушенного твердого вещества, полученного на стадии (e) по п.3 в растворителе, ! (ii) фильтрования любых твердых примесей из раствора, ! (iii) промывки дополнительным растворителем, ! (iv) добавления раствора к очищенной воде, которую поддерживают при температуре приблизительно 78-88°С с образованием таким образом суспензии, ! (v) перемешивания суспензии, ! (vi) охлаждения суспензии, ! (vii) фильтрования, ! (viii) промывки содержимого фильтра водой и далее этанолом и ! (ix) сушки оставшегося твердого вещества под вакуумом при температуре, которая не превышает 40°С. ! 5. Способ по п.4, где растворитель, используемый на стадиях (i) и (iii), представляет собой диметилсульфоксид. ! 6. Способ по п.5, гд 1. The method of obtaining (1- {9 - [(4S, 2R, 3R, 5R) -3,4-dihydroxy-5- (hydroxymethyl) oxolan-2-yl] -6-aminopurin-2-yl} pyrazol-4 -yl) -N-methylcarboxamide! ! by contacting the compounds of formula (4):! ! with aqueous methylamine at a temperature of approximately 2.5-7.5 ° C. ! 2. The method according to claim 1, where the reaction is carried out in a sealed reactor under pressure. ! 3. The method according to claim 2, where the product is isolated by! (a) degassing under vacuum at a temperature not exceeding 35 ° C to remove excess methylamine,! (b) venting and cooling to 0-5 ° C for approximately 15 minutes to an hour,! (c) filtering the suspension thus formed,! (d) washing the contents of the filter with water and then with ethanol and! (e) drying the remaining solid under vacuum at a temperature that does not exceed 40 ° C. ! 4. The method according to claim 3, where the final product is (1- {9 - [(4S, 2R, 3R, 5R) -3,4-dihydroxy-5- (hydroxymethyl) oxolan-2-yl] -6-aminopurine- 2-yl} pyrazol-4-yl) -N-methylcarboxamide is further purified by! (i) dissolving the dried solid obtained in step (e) according to claim 3 in a solvent,! (ii) filtering any solid impurities from the solution,! (iii) rinsing with additional solvent,! (iv) adding a solution to the purified water, which is maintained at a temperature of about 78-88 ° C. to thereby form a suspension! (v) stirring the suspension! (vi) cooling the suspension,! (vii) filtering,! (viii) washing the contents of the filter with water and then with ethanol and! (ix) drying the remaining solid under vacuum at a temperature that does not exceed 40 ° C. ! 5. The method according to claim 4, where the solvent used in stages (i) and (iii) is dimethyl sulfoxide. ! 6. The method according to claim 5, gd
Claims (16)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2009146829/04A RU2443708C2 (en) | 2007-05-17 | 2007-05-17 | Method of producing a2a-adenosine receptor agonist and polymorphic modifications thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2009146829/04A RU2443708C2 (en) | 2007-05-17 | 2007-05-17 | Method of producing a2a-adenosine receptor agonist and polymorphic modifications thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2009146829A true RU2009146829A (en) | 2011-06-27 |
RU2443708C2 RU2443708C2 (en) | 2012-02-27 |
Family
ID=44738562
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2009146829/04A RU2443708C2 (en) | 2007-05-17 | 2007-05-17 | Method of producing a2a-adenosine receptor agonist and polymorphic modifications thereof |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2443708C2 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6403567B1 (en) * | 1999-06-22 | 2002-06-11 | Cv Therapeutics, Inc. | N-pyrazole A2A adenosine receptor agonists |
CN101392012A (en) * | 2002-02-19 | 2009-03-25 | Cv医药有限公司 | Partial and full agonists of A1 adenosine receptors |
-
2007
- 2007-05-17 RU RU2009146829/04A patent/RU2443708C2/en active
Also Published As
Publication number | Publication date |
---|---|
RU2443708C2 (en) | 2012-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2008131956A (en) | METHOD FOR OBTAINING A2A-Adenosine Receptor Agonist and Its Polymorphs | |
KR20090116781A (en) | Method for preparing benzimidazole derivatives | |
EP2966071A1 (en) | Process for producing 1-triazole-2-butanol derivatives | |
WO2012010788A1 (en) | Process for preparing aminobenzoylbenzofuran derivatives | |
US10208057B2 (en) | Nucleator composition comprising sorbitol acetal, sorbitol diacetal and sorbitol triacetal | |
HUE025273T2 (en) | Method for the production of 4-(4-aminophenyl)-3-morpholinon | |
EP3822259A1 (en) | Method for synthesizing valsartan | |
WO2013079866A1 (en) | Method for preparing 5-amino-benzoyl-benzofuran derivatives | |
WO2020141081A1 (en) | Process for synthesizing s-triazine compounds | |
JP5256029B2 (en) | Method for producing 3,7-diaza-bicyclo [3.3.1] nonane compound | |
HUE026880T2 (en) | Methods of making hiv attachment inhibitor prodrug compound and intermediates | |
RU2009146829A (en) | METHOD OF OBTAINING A2A-ADENOSINE RECEPTOR AGONIST AND ITS POLYMORPHIC MODIFICATIONS | |
JP5954989B2 (en) | Method for producing N-alkyl (alkyl) acrylamide and method for producing N-alkyl (meth) acrylamide | |
KR100814597B1 (en) | Separation Method of Methyl 4-formylbenzoate and Dimethylterephthalate | |
RU2009115852A (en) | METHOD FOR PRODUCING ABACAWIR | |
EP1888603B1 (en) | Method of preparing organosilicon compounds | |
CN114591187B (en) | Preparation method of 1,3-bis (tris (hydroxymethyl) methylamino) propane | |
CN112125864B (en) | Synthesis method of 1,1 '-diamino-5, 5' -bitetrazole | |
CA2412543A1 (en) | Process for the preparation of quinoline derivatives | |
KR101305053B1 (en) | Method for Producing Carbamic Acid Derivative Powder | |
US20080262268A1 (en) | Crystallization Method for Benzphetamine | |
EP1265908A1 (en) | Method for preparing 9-deoxo-8a-aza-(8a-alkyl)-8a-homoerythromycin a derivatives from 9-deoxo-9(z)-hydroxyiminoerythromycin a | |
US20140371457A1 (en) | Process for production of quinuclidine compounds | |
CZ9903898A3 (en) | Isoquinoline purification process | |
CN104817546A (en) | Method for recovering olmesartan medoxomil mother solution |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PD4A | Correction of name of patent owner | ||
PC41 | Official registration of the transfer of exclusive right |
Effective date: 20140702 |
|
TC4A | Altering the group of invention authors |
Effective date: 20190409 |